Up a level |
Schegk, E.; Beiser, I; Achtnichts, L; Nedeltchev, K; Bertschi, M; Gschwind, M (2023). Untreated anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years. Journal of neurology, 270(6), pp. 3258-3260. Springer 10.1007/s00415-023-11632-2
Kamm, Christian Philipp; Barin, L; Gobbi, C; Pot, C.; Calabrese, P; Salmen, Anke; Achtnichts, L; Kesselring, J; Puhan, M A; von Wyl, V. (2020). Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study. Journal of neurology, 267(1), pp. 153-161. Springer-Medizin-Verlag 10.1007/s00415-019-09563-y
Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073